Skip to main content
Equibles

BANK OF AMERICA CORP /DE/

Bank

Position in INMB — Inmune Bio, Inc.

CIK 70858 CHARLOTTE, NC
Back to INMB Full portfolio

Position in INMB

as of Mar 31, 2026 · filed May 18, 2026
Position Value
$28,817
-$106 QoQ
Shares Held
25,502
+37.5% QoQ
Ownership
0.092%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in INMB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,039,178 $1,509,650,884
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,291,053 $805,023,185
3 CYTK
Cytokinetics Inc
 4,635,709 $394,916,048
4 ARGX
Argenx SE
 400,234 $371,325,094
5 ALNY
Alnylam Pharmaceuticals, Inc.
 994,476 $299,367,107
6 JAZZ
Jazz Pharmaceuticals plc
 1,136,091 $273,763,844
7 TVTX
Travere Therapeutics, Inc.
 4,568,341 $259,527,450
8 RPRX
Royalty Pharma plc
 4,149,422 $232,658,090

All Filings in INMB

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $28,817 25,502
2025-12-31 $28,923 18,541
2025-09-30 $21,087 10,187
2025-06-30 $28,119 12,173
2025-03-31 $237,368 30,393
2024-12-31 $142,196 30,449
2024-09-30 $142,478 26,434
2024-06-30 $103,775 11,766
2024-03-31 $103,023 8,768
2023-12-31 $158,889 14,111
2023-09-30 $30,268 4,471
2023-06-30 $40,596 4,471
2023-03-31 $30,471 4,717
2022-12-31 $11,862 1,871
2022-09-30 $11,519 1,858
2022-06-30 $16,424 1,858
2022-03-31 $29,958 3,558
2021-12-31 $38,443 3,769
2021-09-30 $34,936 1,799
2021-06-30 $29,869 1,700
2021-03-31 $20,196 1,700
2020-12-31 $29,274 1,700
2020-09-30 $27,837 2,700
2020-06-30 $8,993 1,713
2020-03-31 $5,661 1,700